DXCM
DexCom, Inc.
Medical Devices · Healthcare · United States
79.93
close · 2026-10-29
value
14
cheaper than peers14
quality
94
stronger fundamentals94
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 25.58× | 44 |
| EV to EBITDA | 20.75× | 28 |
| price to sales | 6.07× | 20 |
| price to book | 11.51× | 10 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 38.5% | 98 |
| operating margin | 24.3% | 96 |
| revenue growth | 13.1% | 62 |
| debt to equity | 53.3% | 50 |
4 of 4 measures available
Facts
| market cap | $30B |
| free cash flow | $1.02B |
| employees | 11,000 |
| first trade | 2005-04-14 |
| next earnings | 2026-10-29 |
| fundamentals updated | 2026-10-29 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 | 2021 |
| diluted eps | 2.09 | 1.42 | 1.30 | 0.82 | not reported |
| free cash flow | $1.08B | $630.7M | $511.9M | $304.7M | not reported |
| net income | $836.3M | $576.2M | $541.5M | $341.2M | not reported |
| revenue | $4.66B | $4.03B | $3.62B | $2.91B | not reported |
| unusual items | not reported | not reported | $0 | $0 | -$100,000 |